Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 07, 2024

SELL
$0.48 - $0.7 $216 - $315
-450 Reduced 2.89%
15,100 $8,000
Q1 2023

May 09, 2023

BUY
$0.68 - $1.25 $272 - $500
400 Added 2.64%
15,550 $11,000
Q4 2022

Feb 07, 2023

SELL
$0.96 - $1.34 $960 - $1,340
-1,000 Reduced 6.19%
15,150 $16,000
Q3 2022

Nov 14, 2022

SELL
$1.02 - $2.23 $1,275 - $2,787
-1,250 Reduced 7.18%
16,150 $19,000
Q1 2022

May 04, 2022

SELL
$1.54 - $3.71 $2,002 - $4,823
-1,300 Reduced 6.95%
17,400 $34,000
Q3 2021

Nov 10, 2021

SELL
$2.77 - $4.05 $8,310 - $12,150
-3,000 Reduced 13.82%
18,700 $63,000
Q2 2021

Aug 16, 2021

BUY
$1.71 - $4.14 $37,107 - $89,838
21,700 New
21,700 $83,000
Q2 2021

Aug 06, 2021

SELL
$1.71 - $4.14 $18,126 - $43,884
-10,600 Closed
0 $0
Q1 2021

May 12, 2021

BUY
$0.85 - $5.27 $9,010 - $55,861
10,600 New
10,600 $29,000

Others Institutions Holding SENS

About Senseonics Holdings, Inc.


  • Ticker SENS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 465,447,008
  • Market Cap $610M
  • Description
  • Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...
More about SENS
Track This Portfolio

Track Formidable Asset Management, LLC Portfolio

Follow Formidable Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Formidable Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Formidable Asset Management, LLC with notifications on news.